Inadequate Use of Acid-Suppressive Therapy in Hospitalized Patients and Its Implications for General Practice
- 1 December 2005
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 50 (12) , 2307-2311
- https://doi.org/10.1007/s10620-005-3052-4
Abstract
Acid-suppressive therapy (AST) is largely prescribed in both hospital and general practice setting but few data are available on appropriateness of AST use in hospitalized patients and its fallout on prescribing in general practice. We assessed AST in patients consecutively admitted to an internal medicine department to determine the type and timing of prescription and indication for use according to widely accepted guidelines. Prescriptions were rated as indicated, acceptable, or not indicated. Overall, 58.7% of 834 admitted patients received AST, mainly proton pump inhibitors. The prescriptions were indicated in 50.1% of patients, not indicated in 41.5%, and acceptable in 6.5%. The main reason for inappropriate use was prophylaxis in low-risk patients (64.8%). On admission, 35.7% of 112 patients already on AST were judged to receive inappropriate prescription; of 348 patients discharged on AST, overuse was identified in 38.5%. No significant difference was observed for inappropriate use at admission, during hospitalization, and at discharge. In 64 inpatients (7.7%) AST, although indicated, mainly for ulcer prophylaxis in high-risk patients, was not prescribed. In conclusion, AST is substantially over-used in both hospital and general practice settings, mainly for ulcer prophylaxis in low-risk patients. On the other hand, AST is underused in a small, but not negligible proportion of high-risk patients.Keywords
This publication has 34 references indexed in Scilit:
- Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 2002
- Reducing community dyspepsia drug costs: a controlled trialGut, 2001
- Epidemiology of NSAID-related gastroduodenal mucosal injuryBest Practice & Research Clinical Gastroenterology, 2001
- Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux diseaseBest Practice & Research Clinical Gastroenterology, 2001
- Current indications for acid suppressants in Helicobacter pylori -negative ulcer diseaseBest Practice & Research Clinical Gastroenterology, 2001
- A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1998
- Individual Nonsteroidal Antiinflammatory Drugs and Other Risk Factors for Upper Gastrointestinal Bleeding and PerforationEpidemiology, 1997
- Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of GastroenterologyJAMA, 1996
- Repeat prescribing of ulcer healing drugs in general practice—prevalence and underlying diagnosisAlimentary Pharmacology & Therapeutics, 1996
- Corticosteroids and peptic ulcer: meta‐analysis of adverse events during steroid therapyJournal of Internal Medicine, 1994